Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
O00244
UPID:
ATOX1_HUMAN
Alternative names:
Metal transport protein ATX1
Alternative UPACC:
O00244; A8KAJ8; D3DQI2; Q2M1R6; Q56AP3
Background:
Copper transport protein ATOX1, also known as Metal transport protein ATX1, plays a crucial role in cellular processes by binding and delivering cytosolic copper to copper ATPase proteins. This function is vital for maintaining cellular copper homeostasis and contributes to the cellular antioxidant defense mechanism.
Therapeutic significance:
Understanding the role of Copper transport protein ATOX1 could open doors to potential therapeutic strategies. Its involvement in copper homeostasis and antioxidant defense highlights its importance in cellular health and disease prevention.